To reconcile these seemingly contradictory conclusions, scholars have suggested that while certain immune markers such as PD-1, PD-L1, and OX40L expressed in immune cells correlate with longer progression-free survival (PFS), OX40 expression in tumor cells is associated with shorter PFS [33]. This evidence concerns the gene TNFRSF4 and neoplasm.